1. A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues. Issue 4 (April 2017) Authors: Franck, S E; Korevaar, T I M; Petrossians, P; Daly, A F; Chanson, P; Jaffrain-Réa, M L; Brue, T; Stalla, G K; Carvalho, D; Colao, A; Hána, V; Delemer, B; Fajardo, C; van der Lely, A J; Beckers, A; Neggers, S J C M M Journal: European journal of endocrinology Issue: Volume 176:Issue 4(2017) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabergoline for Cushing's disease: a large retrospective multicenter study. Issue 3 (March 2017) Authors: Ferriere, A; Cortet, C; Chanson, P; Delemer, B; Caron, P; Chabre, O; Reznik, Y; Bertherat, J; Rohmer, V; Briet, C; Raingeard, I; Castinetti, F; Beckers, A; Vroonen, L; Maiter, D; Cephise-Velayoudom, F L; Nunes, M L; Haissaguerre, M; Tabarin, A Journal: European journal of endocrinology Issue: Volume 176:Issue 3(2017) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours. Issue 12 (1st December 1999) Authors: Patey, M; Delemer, B; Bellon, G; Martiny, L; Pluot, M; Haye, B Journal: Journal of clinical pathology Issue: Volume 52:Issue 12(1999) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗